ACELYRIN, Inc.
SLRNDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962918
ACELYRIN, Inc. was delisted in 2025; its insiders filed their last Form 4 on May 23, 2025; 106 institutions reported holding it in 13F filings for Q1 2025, worth $182.7M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by ACELYRIN, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for ACELYRIN, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Goel David E. | Director, 10% Owner, Other: See Remarks | 0Indirect | May 23, 2025 | 0 |
| AyurMaya Capital Management Company, LP | Director, 10% Owner, Other: See Remarks | 0Indirect | May 23, 2025 | 0 |
| Seidenberg Beth C | Director | 0Indirect | May 23, 2025 | 0 |
| Cozadd Bruce C | Director | – | May 23, 2025 | 0 |
| Machado Patrick | Director | 0Indirect | May 23, 2025 | 0 |
| Svoronos Dawn | Director | 0 | May 23, 2025 | 0 |
| Tetrault Lynn A. | Director | – | May 23, 2025 | 0 |
| Gosebruch Henry O | Director | 0 | May 23, 2025 | 0 |
| Kim Mina | Chief Executive Officer | 0 | May 23, 2025 | 0 |
| Becker Daniel J. | Director | 0 | May 23, 2025 | 0 |
| Murugan Amar | Chief Legal Officer | 0 | May 23, 2025 | 0 |
| Mpofu Shephard | Chief Medical Officer | 0 | May 23, 2025 | 0 |
| Labrucherie Gil M | CFO and CBO | 40,763Indirect | Sep 4, 2024 | 0 |
| Gloria Melanie | Chief Operating Officer | 130,286 | May 24, 2024 | 0 |
| Pangali Sanam | CLO & Head of People | 74,154 | May 24, 2024 | 0 |
| Lin Shao-Lee | Chief Executive Officer | 1,577,374 | Apr 3, 2024 | 0 |
| Oyston Ronald | Chief People Officer | 141,332 | Jan 11, 2024 | 0 |
| Peloso Paul | Chief Medical Officer | 39,133Indirect | Oct 6, 2023 | 0 |
| Harper Sean E | 10% Owner | 9,790,729 | May 11, 2023 | 0 |
| Westlake BioPartners Fund II, L.P. | 10% Owner | 9,790,729 | May 11, 2023 | 0 |
| Westlake BioPartners GP II, LLC | 10% Owner | 9,790,729 | May 11, 2023 | 0 |
| Dier Mardi | CFO and CBO | 875Indirect | May 11, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Kim MinaChief Executive Officer | SSale | −18.0K | $2.74 | −$49.3K | −2.6%671.8K after | |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Murugan AmarChief Legal Officer | SSale | −3.91K | $2.74 | −$10.7K | −3.1%121.6K after | |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Mpofu ShephardChief Medical Officer | SSale | −3.21K | $2.74 | −$8.80K | −2.6%121.8K after | |
| Jul 19, 2024 (view filing) | Jul 17 | 2 days | Becker Daniel J.Director | SSale | −1 | $6.86 | −$6.86 | 0.0%3.00K after | |
| Apr 3, 2024 (view filing) | Apr 1 | 2 days | Lin Shao-LeeChief Executive Officer | SSale | −9.96K | $6.63 | −$66.0K | −0.6%1.58M after | |
| Feb 22, 2024 (view filing) | Feb 20 | 2 days | Lin Shao-LeeChief Executive Officer | SSale | −15.7K | $7.60 | −$119.3K | −1.0%1.59M after | |
| Jan 4, 2024 (view filing) | Jan 2 | 2 days | Lin Shao-LeeChief Executive Officer | SSale | −10.7K | $7.41 | −$79.2K | −0.7%1.60M after | |
| May 11, 2023 (view filing)9:16 PM ET | May 9 | 2 days | Harper Sean E and 2 others10% Owner | PPurchase | +1.25M | $18.00 | +$22.5M | +14.6%9.79M after | Duplicate filing |
| May 11, 2023 (view filing) | May 9 | 2 days | Seidenberg Beth CDirector, 10% Owner | PPurchase | +1.25M | $18.00 | +$22.5M | +14.6%9.79M after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Seidenberg Beth CDirector, 10% Owner | PPurchase | +60.0K | $18.00 | +$1.08M | New position60.0K after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Svoronos DawnDirector | PPurchase | +15.0K | $18.00 | +$270.0K | New position15.0K after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Gosebruch Henry ODirector | PPurchase | +50.0K | $18.00 | +$900.0K | New position50.0K after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Becker Daniel J.Director | PPurchase | +3.00K | $18.00 | +$54.0K | New position3.00K after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Oyston RonaldChief People Officer | PPurchase | +1.00K | $18.00 | +$18.0K | New position1.00K after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Oyston RonaldChief People Officer | PPurchase | +26 | $18.00 | +$468 | New position26 after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Kim MinaChief Legal & Admin. Officer | PPurchase | +5.00K | $18.00 | +$90.0K | New position5.00K after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Peloso PaulChief Medical Officer | PPurchase | +6.00K | $18.00 | +$108.0K | New position6.00K after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Dier MardiCFO and CBO | PPurchase | +5.56K | $18.00 | +$100.0K | New position5.56K after | |
| May 11, 2023 (view filing) | May 9 | 2 days | Dier MardiCFO and CBO | PPurchase | +1.75K | $18.00 | +$31.5K | New position875 after | 2 lots |